G, S., A, R., NW, S., A, L., C, T., A, O., . . . C, S. (2013). Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study. International journal of cancer, 133(5), 1204. https://doi.org/10.1002/ijc.28111
Chicago Style (17th ed.) CitationG, Stragliotto, et al. "Effects of Valganciclovir as an Add-on Therapy in Patients with Cytomegalovirus-positive Glioblastoma: A Randomized, Double-blind, Hypothesis-generating Study." International Journal of Cancer 133, no. 5 (2013): 1204. https://doi.org/10.1002/ijc.28111.
MLA (9th ed.) CitationG, Stragliotto, et al. "Effects of Valganciclovir as an Add-on Therapy in Patients with Cytomegalovirus-positive Glioblastoma: A Randomized, Double-blind, Hypothesis-generating Study." International Journal of Cancer, vol. 133, no. 5, 2013, p. 1204, https://doi.org/10.1002/ijc.28111.